Yongjun Liu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial.
Journal: Frontiers in immunology
Published: April 07, 2026
Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord-Derived Mesenchymal Stem Cell-Mediated Rheumatoid Arthritis Therapy.
Journal: Cell transplantation
Published: January 20, 2025
A new era of gene and cell therapy for cancer: a narrative review.
Journal: Annals of translational medicine
Published: August 05, 2022
Effects of different concentrations of mesenchymal stem cells treatment on LPS-induced acute respiratory distress syndrome rat model.
Journal: Experimental lung research
Published: March 22, 2021
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study.
Journal: Drug design, development and therapy
Published: August 01, 2019
SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 09, 2014
Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy.
Journal: Stem cells and development
Published: August 15, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026